Trial Profile
Persistence rate of mirabegron therapy in patients with overactive bladded
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2018 New trial record